EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A

Michael W Brigham iD, Edward S Hems iD, Daniel C L Van iD, Justin E Clarke iD, Sergey Nepogodiev iD, Julius S P Adamson iD, Christian Bassi iD, Michael E Webb iD, Glyn R Hemsworth iD, Orde Q Munro iD, Barrie Wilkinson iD, Ryan F Seipke iD

Angewandte Chemie International Edition · 22.06.2026 · 65 (26)

DOI: 10.1002/anie.202511349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.05.2026. Verfasst von Michael W Brigham und 11 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Glycopeptides, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: White Rose Mechanistic Biology Doctoral Training Programme funded by BBSRC, BBSRC via the Institute Strategic Programme Grant 'Harnessing Biosynthesis for Sustainable Food and Health' (HBio), BBSRC responsive mode grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical deployment of antibiotics is undermined by antimicrobial resistance. Without new agents to treat antibiotic‐resistant bacterial infections, mortality rates are predicted to reach 10 million people per year by 2050. Most antibiotics are derived from natural products (NPs) produced by bacteria; however, this resource was abandoned by industry because of high rediscovery rates. We are amid a natural product renaissance fuelled by inexpensive access to genome sequencing and sophisticated bioinformatic tools, which have highlighted that most of the biosynthetic pathways for NPs are not expressed in the laboratory. Here, we engineered the expression of a silent biosynthetic gene cluster harboured by an environmental isolate of Streptomyces albidoflavus . Using a bioinformatics‐guided approach, we isolated and structurally characterised a novel glycopeptide antibiotic (GPA) named biffamycin A, which is the smallest GPA known and harbours unprecedented 5‐chloro‐4‐methoxy tryptophan and 3‐hydroxy(α‐D‐mannoysl)‐D‐lysine moieties. Biffamycin A possesses antimycobacterial and antistaphylococcal bioactivity, including against methicillin‐ and vancomycin‐resistant Staphylococcus aureus .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsGlycopeptidesDrug DiscoveryStreptomycesMultigene FamilyMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Streptomycesamino acid hydroxylaseglycopeptide antibioticsnatural product biosynthesissilent gene clusters

Substanzen

Anti-Bacterial AgentsGlycopeptides

Autor:innen und Institutionen

  • Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
  • Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, UK.
  • Centre For Microbial Interactions, Norwich Research Park, Norwich, UK.
  • NMR Platform, John Innes Centre, Norwich, UK.
  • Astbury Centre for Structural Molecular Biology, School of Chemistry, University of Leeds, Leeds, UK.
  • School of Chemistry, University of Leeds, Leeds, UK.

ORCID-Profile: Michael W Brigham, Edward S Hems, Daniel C L Van, Justin E Clarke, Sergey Nepogodiev, Julius S P Adamson, Christian Bassi, Michael E Webb, Glyn R Hemsworth, Orde Q Munro, Barrie Wilkinson, Ryan F Seipke

Förderung

  • White Rose Mechanistic Biology Doctoral Training Programme funded by BBSRC
  • BBSRC via the Institute Strategic Programme Grant 'Harnessing Biosynthesis for Sustainable Food and Health' (HBio)
  • BBSRC responsive mode grant
  • Wellcome Trust Doctoral Training Programme

Zitieren

APA

Brigham, M. W., Hems, E. S., Van, D. C. L., Clarke, J. E., Nepogodiev, S., Adamson, J. S. P., Bassi, C., Webb, M. E., Hemsworth, G. R., Munro, O. Q., Wilkinson, B., & Seipke, R. F. (2026). Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A. Angewandte Chemie International Edition, 65(26). https://doi.org/10.1002/anie.202511349

Vancouver

Brigham MW, Hems ES, Van DCL, Clarke JE, Nepogodiev S, Adamson JSP, et al. Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A. Angewandte Chemie International Edition. 2026;65(26). doi:10.1002/anie.202511349

BibTeX
@article{Brigham2026,
  author = {Brigham, Michael W and Hems, Edward S and Van, Daniel C L and Clarke, Justin E and Nepogodiev, Sergey and Adamson, Julius S P and Bassi, Christian and Webb, Michael E and Hemsworth, Glyn R and Munro, Orde Q and Wilkinson, Barrie and Seipke, Ryan F},
  title = {Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {26},
  doi = {10.1002/anie.202511349}
}
Kostenlos starten →